FIELD: pharmaceutics.
SUBSTANCE: present invention relates to lyophilized compositions containing daptomycin and at least two amino acids, methods for producing such compositions and their use.
EFFECT: obtaining daptomycin preparations.
15 cl, 5 ex, 12 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHODS FOR IMPROVEMENT OF ORAL ABSORPTION OF ANTIBACTERIAL AGENTS | 2001 |
|
RU2282462C2 |
| STABLE AQUEOUS COMPOSITIONS OF PROTEIN MIA/CD-RAP | 2011 |
|
RU2588658C2 |
| AQUEOUS COMPOSITION CONTAINING DANTROLENE | 2016 |
|
RU2729043C2 |
| METHOD OF CONTROLLING MODIFICATION REACTION OF POLYPEPTIDE | 2009 |
|
RU2532850C2 |
| LYOPHILISED PREPARATION OF CYTOTOXIC DIPEPTIDES | 2012 |
|
RU2597154C2 |
| LIPOPEPTIDE COMPOSITION AND RELATED METHODS | 2010 |
|
RU2607526C2 |
| PHARMACEUTICAL PREPARATION CONTAINING EGF RECEPTOR ANTIBODY | 2004 |
|
RU2381036C2 |
| COMPOSITION CONTAINING HIGHLY CONCENTRATED ALPHA-1-PROTEINASE INHIBITOR AND METHOD OF ITS PREPARATION | 2019 |
|
RU2813136C1 |
| METHOD OF PURIFYING LIPOPEPTIDE (OPTIONS) AMD ANTIBIOTIC COMPOSITION BASED ON PURIFIED LIPOPEPTIDE (OPTIONS) | 2001 |
|
RU2311460C9 |
| LIQUID PREPARATION CONTAINING OLIGOPEPTIDES AND ESTERIFIED CYCLODEXTRIN | 2003 |
|
RU2322254C2 |
